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Transgenic crops offer the state-of-th -art, and yet simple-to-use technologies for sustainable en-
hancement of agricultural productivity. During the last 20 years, several research groups in India 
have developed capabilities in genetic engineering of crop plant species and some of them have is-
lated promising genes and promoters, with potential for commercialization. However, isolated 
growth of researchers, limited R&D infrastructure and knowledge base available in the seed industry, 
and the regulatory processes involved in the release of transgenic cultivars pose serious challenges 
to accelerating the conversion of such leads into field crops. There is an urgent need to evolve effi-
cient managerial approaches for developing and advancing genetically engineered cultivars into 
Indian agriculture. This article emphasizes the need to identify the most promising transgenics and 
genes available in the country, evaluate the related intellectual property issues and provide un-
stinted support to accelerate the process of their commercialization. An approach that would syn-
ergize public–public and public–private partnerships needs to be evolved. Initially, it may be driven 
by public sector through crop- and trait-specific consortia, comprising researchers and the seed 
industry. A few of such examples should be taken to the stage of clearance by GEAC for unregu-
lated release of indigenously developed transgenic cultivars. These would then serve as role models 
and catalyse the formation of need-based teams and lasting partnerships, needed to usher Indian 
agriculture into a globally competitive phase of sustainable productivity. 
 
IT has been amply demonstrated that genetically engineered 
(GE) seeds, developed using recombinant-DNA techniques 
(also referred to as transgenics, or genetically modified 
organisms (GMOs)), provide an easily adaptable, scale-
neutral technology for the farmers. Even farmers with small 
land holdings can benefit from the high technology when 
such seeds become available to them at reasonable cost. 
Changes required in the existing crop management practices, 
or additional inputs are minimal. The Task Force on Agriul-
tural Biotechnology constituted rec ntly by the Ministry of 
Agriculture recommended1 that ‘High priority should be 
accorded in transgenic approach to the incorporation of 
resistance to insect-pests and diseases, including viruses 
and to drought and salinity (i.e. biotic and abiotic stresses)’. 
Genetic engineering provides great opportunities to enhance 
crop productivity, reduce the amount of pesticides applied 
in the field, and bring down the cost of production. Many 
laboratories in the country have been engaged in GE of crop 
plants for several years2. However, the progress in commer-
cializing the indigenously developed GE crops has been 
slow. Even globally, only two traits– herbicide and insect 
resistance have been deployed extensively in the development 
of transgenic cultivars. This point was also made by Pental3: 
‘How is it that while in the laboratories a large number of 
transgenics have been developed – very few are in the field?’ 
This article addresses the issue of converting laboratory 
demonstrations of GE crop plants into marketable cultivars 
nd hybrids for large-scale cultivation in India, and suggests 
me sur  to expedite this process. 
The global and Indian scene 
Globally, transgenic crops were grown during 2003 on nearly 
70 mha of land4. In contrast, the coverage in India was less
than 100,000 ha compared to 2.8 mha in China. The first, 
and as yet, the only GE crop permitted for commercial 
cultivation in India is cotton that expresses a d-endotoxin 
gene (cry1Ac) from Bacillus thuringiensis for bollworm 
resistance, popularly known as Bt-cotton. Three hybrids 
with the Bt gene were approved for planting by the farmers 
in 2002. These were developed by the Maharashtra Hybrid 
Seeds Company (MAHYCO), using the technology licensed 
from Monsanto Co, St. Louis. Convinced by the overall 
performance of Bt-cotton, several other smaller seed com-
panies have now entered into licensing arrangements with 
Monsanto for the same gene, in spite of the high cost of 
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technology transfer. This illustrates that even small seed 
companies are willing to invest funds when they are con-
vinced about the advantage and expected returns. Precedence 
of bio-safety approval from the regulatory authority (GEAC) 
for the gene, makes them comfortable with their investment 
decision in this case. 
 At the same time, opposition in many parts of the world, 
including India, against the cultivation of GE crops has 
hindered their commercialization. Indian opposition is not 
as much against GE technology, but is primed by fears re-
lated to possible dependence of Indian seed companies on 
imported technologies from multinational corporations 
(MNCs). There are widespread apprehensions in India even 
among senior agricultural scientists that the high technology 
seeds in the hands of MNCs, in future, may make the Indian 
farmers largely dependent on them for their seed require-
ments. The authors believe that competition between imported 
and indigenously developed technologies can provide a wider 
choice of seeds to the farmers at equitable costs. Pharma-
ceutical industry in the country is a good example of growth 
catalysed by such competition. Generic drugs from multi-
ple, local manufacturers have been helpful in keeping a 
check on the prices charged to the consumers. In recent 
years, public and private sector networking has also led to the 
identification of new drug molecules. Some of the private 
players in the pharma industry are poised to become MNCs 
of Indian origin. Availability of proprietary (private) as well 
as public-bred hybrid seeds in the past few years in India 
indicates that, farmers benefit from wider options, and se-
lect the hybrids that give them higher economic returns. 
Continual improvements are made by the seed producers 
to enhance their market share. The authors believe that in 
the high-technology areas of GE seeds, there is need for the 
public-funded research laboratories to establish comple-
menting partnerships with the private seed industry. This 
alone can ensure expedient development, and adequate 
availability of quality seeds packaged with the state-of-
the-art technologies, matching the global advances made by 
MNCs. 
 The organized seed market in India is less than 3% of the 
global market, which is estimated at about US$ 30 billion. 
The purchased seed covers only 10% of the total area 
planted5 in the country, the rest is sown either with the seed 
saved at the farm or obtained from neighbouring farmers. 
This huge gap needs to be reduced by enhancing awareness 
of, and supplying quality seeds. In the absence of variety 
protection, private seed companies largely restrict themselves 
to the selling of hybrids where the parental stocks remain 
with the company. The same would be true for the GE seeds; 
private seed companies would prefer selling mainly the 
hybrids, where new seed needs to be bought each year from 
the company. The seed saved from the harvest, if used for 
planting, gives lower productivity due to segregation. In this 
respect, public sector institutes need to play the benevo-
lent role of developing GE cultivars in crops where hybrids 
are not feasible. Heterotic breeding should be preferred for 
crop  where the increased productivity compensates for the 
higher cost of hybrid seed. This would further promote 
initiatives from private seed companies. The Chinese ap-
proach to Bt-cotton is worth mentioning in this context. 
China licensed cultivation of imported Bollgard t-cotton 
developed by Monsanto in 1997, which was rapidly acce -
t d6. At the same time, indigenously developed hybrid cotton 
with locally isolated Bt genes was also introduced in 1998. 
I 2002, Bollgard and locally developed Bt-hybrids respec-
tively, covered 55 and 45% of the total Bt-c ton area. Thus 
the Chinese Academy of Agricultural Sciences has already 
set up an example by evolving an alternative to Bt-cotton 
from Monsanto. India can also open new opportuni ies by exe-
cuti g a carefully planned strategy to meet national eeds. 
The local successes 
Excellent leads obtained in genetic enhancement of crop 
plants, using the R-DNA techniques in several laborato-
ries supported by public funds in the country, have been 
listed by Sharma et al.7. During the last few years, among 
others, research laboratories at the Indian Agricultural 
Research Institute, National Botanical Research Institute 
(NBRI), Delhi University (South Campus), International 
Centre for Genetic Engineering and Biotechnology, National 
Centre for Plant Genomic Research, Tamil Nadu Agriculture 
University, Osmania University, International Crop Research 
Institute for Semi-Ar d Tropics, etc. have spent substantial 
efforts towards the development of transgenic crop plants 
improved for resistance to insect pests, disease, drought 
and salinity stress, higher protein content, and male sterility 
for hybrid seed production. The cases where satisfactory 
expression levels have been reported in agricultu al crops 
are listed in Table 1. 
Novel genes and promoters developed at NBRI 
Novel genes8, promoters9 and other related technologies10 
useful for the development of GE crops have been deve-
loped at NBRI, Lucknow. A synthetic gene8 that codes for 
a chim ric protein designed for high level of toxicity to 
an insect, Spodoptera litura h s been designed. This her-
bivore damages a number of crop species, including cotton, 
groundnut, castor and vegetable crops. The novel gene has 
been patented and used for developing transgenic cotton and 
groundnut. A second gene (modified cry1Ac) that targets 
another major pest of cotton (Helicoverpa armigera) has 
also b en designed and synthesized at NBRI. The two trans-
genicBt-cotton lines show a high level of rsistance to 
bollwo ms in laboratory tests. These Bt-cotton lines have 
rec ntly been licensed to Swarnabharat Biotechnics Pvt Ltd, 
Hyderabad, which is a consortium of seven reputed Indian 
seed companies. The contributions of NBRI to the develop-
ment of indigenous Bt-cotton and catalysing partnership 
among several seed companies have received wide attention 
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Table 1. Significant reports on agriculturally useful transgenic crop plants developed in Indian laborator es 
Crop Trait Reference 
 
Cotton Transgenics expressing novel cry1EC and cry1Ac genes for resistance to bollworms  8 
   Spodoptera litura and Helicoverpa armigera 
Brassica juncea  Transgenic male sterile (barnase)/restorer (barstar) lines for heterotic breeding 21 
(Indian mustard) 
Indica rice Transgenics expressing owdrop lectin gene for resistance to sap sucking insects, 22 
   brown planthopper and green leafhopper 
Indica rice Transgenics expressing cry1Ac for resistance to stem borer 23 
Indica rice Transgenics expressing cry1Ac for resistance to yellow stem borer 24 
Potato Transgenics expressing Amaranthus seed albumin for nutritional enhancement 25 
Solanum melongena Transgenics expressing cry1Ac for resistance to fruit borers 26, 27 
 (brinjal), tomato 
Banana Transgenics expressing magainin analogue for enhanced disease resistance 28 
Brinjal Transgenics expressing mannitol phosphodehydrogenase for abiotic stress tolerance 29 
 
 
internationally11 and nationally12. Many other Indian seed 
companies and state-lev l organizations have been pursuing 
CSIR and NBRI for the transfer of Bt-cotton developed at 
the institute. However, a lot remains to be done to ensure 
that the indigenously developed Bt-cotton reaches the field. 
Genes against multiple pests of cotton need to be brought 
together in Indian cultivars. Immunological and genomic 
methods need to be developed to facilitate rapid selection 
of the desired segregants. Thus accelerated development 
of Indian Bt-cotton that would succeed in long run, requires 
further partnerships among Indian research groups and 
more efficent coordination with the industry. 
Slow pace of commercialization 
There is a need to examine what can accelerate and ensure 
the progress of such laboratory-level achievements towards 
sustainable commercialization. Some of the technical reasons 
for the slow progress were briefly discussed earlier13. Transfer 
of the desired genes into crop species, with adequate expres-
sion levels in homozygous, true breeding lines is the first 
step towards the development of commercial ‘product’ 
(cultivar or hybrid). This requires selecting a large number 
of independent transformation events in a genotype suit-
able for regeneration, and identifying those with high and 
stable expression of the transgene. The next major stages 
are: integrating the desired transgenic trait with o her accept-
able agronomic and quality parameters through conven-
tional approaches in plant breeding, food and bio-safety 
evaluation, multi-location agronomic performance trials 
and adequate seed production at all stages. Rapid progress 
through these stages requires the development of molecular 
approaches like immunological and marker-assist d selec-
tion methods for screening the segregating populations. 
Multiplication time can be saved using a combination of tis-
sue culture and planting at multiple locations. Biosafety 
and performance evaluation requires close coordination 
among several institutes and organizations. Only after pass-
ing through these stages can the transgenic seeds be deliv-
ered to the farmers. 
 In moving forward at an accelerated pace, the following 
c nstraints are faced by researchers in public institutes, and 
seed companies: 
 
· Lack of physical infrastructure in public-funded, non-
agricultural research institutes and universities, where 
such transgenics have been developed.  
· Different kind ofcompetencies required for the devel-
opment of marketable cultivars/hybrids. Most labora-
tories with capabilities in molecular genetics do not have 
prior experience in this kind of work. 
· Original gene transfers are made as a part of multiple 
Ph D research programmes under a senior scientist. Their 
co version to a marketable ‘product’ requires sus-
tained efforts of the staff. Students and research schol-
ars on fellowships do not find such work attractive. 
· Traditionally, the administrators in public-sector res arch 
organizations and agricultural institutes have mindset 
limitations in the empowerment of scientists, moving 
ahead themselves with efficiency, making the required 
investments by developing expedient partnerships with 
ind stry. 
· Small seed companies do not have the infrastructure to 
adopt physiological, molecular genetic and immunolog-
cal tools required for efficient development, screening 
and selection of the desired transgenic lines. They can 
hire scientific personnel to carry out field experiments, 
but the manpower trained in the state-of-the-art molecu-
lar t chnologies is not easily available, and is much more
expensive to employ. In general, they lack trained human 
resources, and facilities to carry out the molecular work 
needed to expedite the progress. 
· GE technologies are intensively knowledge-driven. 
This makes it difficult for a majority of small seed 
companies to handle genes, transformations, analyse the 
associated IPR issues, and deal with regulatory depart-
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ments. In spite of receiving a technically proven transgenic 
Coker line, even a large seed company like MAHYCO 
could manage these issues apparently due to its partner-
ship with Monsanto, St. Louis. 
· Food safety and bio-safety evaluation involves liaison 
with multiple institutes and high costs. Smaller seed 
companies and one-man-teams (with Ph D students and 
or project research fellows) of research scientists, as 
encountered commonly in India cannot handle these 
by themselves. 
 
As a result of the above constraints, in spite of the national 
need and availability of technical capabilities, commer-
cialization of the indigenously developed transgenics has 
not happened. 
Cost of commercializing a new GE crop  
cultivar/hybrid 
Development of a marketable GE cultivar/hybrid can be as 
expensive as developing a new drug, widely estimated at 
upward of US$ 800 million14,15. The overall cost for the 
development of a marketable ‘product’ is estimated to be at 
least 20-fold higher than the development of homozygous 
transgenic plants16. Some cost estimates for mandatory 
regulatory compliances are available17. The values range 
from US$ 700,000 for papaya to 2.25 million for rice and 
four million for herbicide-resistant soybean in Brazil. In terms 
of time, it took nearly 15 years for Monsanto to develop 
and get the first approval for commercial release of a Bt cr p.
The project concept existed in early 1980 and sufficient 
proof of concept had been published in the form of insect 
resistant transgenic Bt-tobacco18,19 and tomato20 by 1987. 
Yet, it was in 1995 that ‘Bollgard’ cotton and ‘Maximizer’ 
corn were released. The cost of developing the first transgenic 
Ro Bt-cotton line at NBRI under various components sup-
ported by the DBT, CSIR and NATP through the period 
1995 to 2004 was about Rs 3 crores, inclusive of staff 
salaries. Given the advantage of the previously available 
published information, governmental infrastructure and some 
unaccounted overheads and concessions, this may be an 
underestimate. Nevertheless, industry may be able to achieve 
comparable goals in three- to five-fold higher cost in India. 
This is not a high cost compared to the estimates available 
from elsewhere. These estimates indicate the cost competi-
tiveness of undertaking such projects in India. Hence, the 
opportunities are enormous and global, but can be realized 
only through strategically managed partnerships and effi-
cient project execution. The Bt-cotton developed at NBRI 
requires at least another 5 years to introgress the gene into 
agronomically desirable backgrounds and obtain regulatory 
clearances before transgenic cultivars developed indigenously 
can be released for commercial cultivation. The partner 
industry immediately needs immunostrip-based kits against 
the novel protein designed at NBRI. They also need AFLP-
based genomic screening to cut short the number of back-
crosses. 
Mission-mode approach 
Synergizing partnerships and mission-mode approach are 
needed to expedite the development and commercialization 
of GE crops. A road map is needed for the exploitation of 
agronomically promising transgenic crop species already 
available (Table 1) from public-funded research in India. 
The following steps need to be taken: 
 
 (1) Compilation of agronomically useful genes and tran-
genics already available in the country and suitable for 
applications in different crops. 
 (2) Independent evaluation of GE stocks developed for 
the target trait, under containment conditions, if not al-
ready approved for growing in open field. 
 (3) Detailed examination of IPR issues. 
 (4) Ex mination from possible food and environmental 
safety viewpoint based on the literature. 
 (5) Wide publicity to the available stocks, along with 
th terms and conditions for transfer to private, and 
public institutions. Transformation of the genes and 
their pyramiding in priority crops. 
 (6) Compliance to the guidelines by RCGM and permis-
sion for growing transgeics in open field. 
 (7) Initiation of food and environment safety evaluation. 
 (8) Independent backcrossing programmes into agronomi-
cally acceptable genotypes by public ARIs, SAUs (pub-
lic–public partnership) and private seed companies. 
 (9) Initiation of seed multiplication for bio-safety evalu-
tion and field trials after 5–6 backcrosses to the recurrent 
parent. 
(10) Initiation of bio-safety and agronomic evaluation of the 
selected gene–g notype combination. 
 
The above aspects should be pursued in parallel, and by 
undertaking field work at normal and ‘off season’ locati ns. 
Taking Bt-cotton and male sterile barnase–barstar mustard, 
the first role models that would accelerate progress towards 
large-scale applications need to be developed and executed 
successfully. 
A different kind of management and organizational struc-
ture is required to bring together the knowledge centres, 
plant-breeding laboratories, and small-scale seed indus-
tries. The ARIs and SAUs need to leverage the talent and 
materials available in non-agricultural institutions. Inflexibi-
ity of the systems often does not permit this even when 
th re is a strong desire. Statutory rules are such that a plant 
molecular biologist cannot be recruited on faculty positions 
in most SAUs unless he/she holds a B Sc (Agriculture) 
deg ee. In the earlier days of the green revolution, National 
and State Seeds Corporations played a significant role in 
making available the seeds of new cultivars to the farmers. 
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 Establishing Crop and Trait-Specific 
Consortia  
 (based on needs of industrial partners, 
farmers, State Seeds Corpn.) 
Identification of Public and Private 
Partners  
(to deliver genes, transgenics, germ 
plasm, IPR, tools, biosafety, varietal 
development) 
Project Implementation & Monitoring 
(plant transformation, marker assisted 
selection, gene repository, IPR 
acquisition) 
Regulatory Testing 
(ITRC, Sriram Inst., CFTRI, NIN, 
Vimta Labs, etc.) 
 Royalty  
Regional Containment Field acilities 
maintained by SAU & agbiotech parks  
(for transgenic crop breeding and  
biosafety tests) 
 Commercialization (by partner  
industry) 
Performance Trials  
       (approval by GEAC) 
Marketing Arm  
(for overseas trading) 
Application to RCGM  
(for collective clearance)  
DBT 
ICAR 
CSIR 
TDB 
Corpus Fund 
(public, private, venture) 
 
 
Figure 1. Networking plan for accelerating development and commercialization of indigenously developed transgenic crops. 
 
 
However, most of the State Seed Corporations are currently 
operating with huge accumulated losses. Normally, one 
would expect some State Seed Corporations to venture into 
production and marketing of GE seeds. However, current 
experience shows that even the most enlightened ones 
have chosen to keep away for various reasons, including 
the uncertainties related to biosafety and regulatory issues, 
and the non-availability of indigenous transgenics. Estab-
lishment of an autonomous National Biotechnology Regu-
latory Authority, recently recommended by the Task Force
may change this trend, provided an efficient single-window 
Government approval system is established. 
 Some examples of successful commercialization of com-
plex technologies standardized through public-funded res-
earch into marketable products with back-up R&D support 
from leading research centres in the country are: Electronics 
Corporation of India, Nuclear Power Corporation Ltd, 
Haffkine Bio-Pharmaceutical Corporation Ltd, etc. These 
can serve as useful models for GE crops. Researchers in 
public institutions, private seed companies/agri-e trepreneurs 
need to join hands to form consortia aimed t crop-specific, 
goal-oriented commercialization projects. A governmental 
body is needed to provide a platform to bring them together. 
This may be done through a project execution structure of 
the ki d developed by the Council of Scientific and Indus-
trial Research under the NMITLI (New Millennium Indian 
Technology Leadership Initiative) programme for networking
wi h industry. A representative functional plan for developing 
such consortia is given in Figure 1. All stake holders –
Department of Biotechnology, Indian Council of Agricul-
tural Research and Council of Scientific and Industrial 
Research – should initially support such joint endeavours 
with pooled financial resources, supplemented by the 
Technology Development Board. The Department of Sci-
ence and Technology, New Delhi has established a few 
in ubators in the country, a couple of them specifically for 
agri-biotechnology, such as the one at ICRISAT, Hydera-
bad. The facilities developed at these incubators can be used 
by the consortium on project-linked payment basis. The Task 
Force has also recommended Rs 12000 million additional 
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fund during the remaining three years of the TenthPlan. 
Support for mission-mode approach in such projects 
needs to be ensured till the stage of GEAC approval. Fol-
lowing the approval, successful initiatives would attract 
venture funds and larger investments for expanding seed 
production. The suggested approach would facilitate and 
expedite conversion of the laboratory accomplishments 
into crop cultivars/hybrids for the Indian farmers in short 
term, and perhaps open new overseas markets for the seed 
industry in future. A cess on seed sales can make such pro-
grammes financially sustainable in future, without Gov-
ernment support, to continually evolve globally competitive 
genes, transgenics, and technologies in response to the needs 
of the farmers. 
 After the acceptance of this article on 25 November 
2004 we noticed a publication by Joel Cohen released on the 
net on 6 January 2005. The paper entitled ‘Poorer nations 
turn to publicly developed GM crops’, to be published in 
Nature Biotechnology, vol. 23, January 2005 considers on 
global basis, the issues that have been raised by us in this 
article in the Indian context. The readers would notice several 
commonalities in the issues raised and the approaches 
suggested.  
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